The US Drug Enforcement Administration (DEA) has approved the first clinical trial of MDMA being used to treat patients with debilitating anxiety due to terminal illness, highlighting a changing attitude toward using psychedelic drug therapy on those with severe nervous disorders. Communications Director Brad Burge at the [...]